Brand Name Details: Medication: Tirzepatide Manufacturer: Eli Lilly FDA Approval: May 2022 Approved For: Type 2 diabetes management Dosing: Once-weekly injection Available Doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg List Price: $1,069 per month How Mounjaro Works: Mounjaro activates two hormone receptors: GIP (Glucose-Dependent Insulinotropic Polypeptide) Effects: Enhances insulin secretion when blood sugar is elevated Improves insulin sensitivity May influence fat metabolism Contributes to appetite suppression GLP-1 (Glucagon-Like Peptide-1) Effects: Increases insulin release after meals Decreases glucagon (prevents excess glucose production) Slows stomach emptying Reduces appetite through brain signaling Increases feelings of fullness This dual action produces: Superior blood sugar control Exceptional weight loss (average 15-22% of body weight) Reduced cardiovascular risk factors Improved metabolic health markers What Is Tirzepatide

Not yet Retatrutide is investigational, with realistic availability between the second half of 2027 and mid-2028
Apr 2010;7(4):1508-19
Pituitary signaling: It binds to receptors in the pituitary gland and triggers pulses of growth hormone release
Key details Compounded GLP-1s Semaglutide injections Semaglutide oral lozenges Semaglutide oral drops Semaglutide oral liposomal tablets Tirzepatide injections Tirzepatide oral drops Semaglutide microdose Tirzepatide microdose Tirzepatide oral tablets Branded GLP-1s Wegovy (pen and pill) Zepbound Ozempic Mounjaro ShedRx offers both semaglutide and tirzepatide microdose options, as well as non-GLP-1 weight-loss medications and a range of supplements for hair, sleep, and longevity, including NAD+
Kingdom providers evaluate each patient individually to determine whether wellness treatment is clinically appropriate.